Katherine Anne Marzan
Division Chief of Rheumatology
Interim Director of the Infusion Center
Contact
Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study Arthritis Rheumatol. 2021 02; 73(2):336-346. . View in PubMed
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial Lancet. 2021 11 27; 398(10315):1984-1996. . View in PubMed
Burden of illness in hereditary periodic fevers: a multinational observational patient diary study Clin Exp Rheumatol. 2020 Sep-Oct; 38 Suppl 127(5):26-34. . View in PubMed
Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study Arthritis Rheumatol. 2020 12; 72(12):2147-2158. . View in PubMed
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results Arthritis Care Res (Hoboken). 2020 10; 72(10):1420-1430. . View in PubMed
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial Ann Rheum Dis. 2020 10; 79(10):1362-1369. . View in PubMed
Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals Children (Basel). 2018 Nov 21; 5(11). . View in PubMed
Do pedometers with or without education on exercise increase functional walking capacity and physical activity level in adolescents with juvenile idiopathic arthritis? Physiother Theory Pract. 2018 May; 34(5):359-366.. View in PubMed
Benign pneumatosis intestinalis in a pediatric patient with multiple risk factors including granulomatosis with polyangiitis: a case report and review of the literature Semin Arthritis Rheum. 2015 Feb; 44(4):423-7. . View in PubMed
Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study J Clin Rheumatol. 2014 Jun; 20(4):183-8. . View in PubMed
Diagnosis and management of infectious complications of childhood rheumatic diseases Curr Rheumatol Rep. 2013 Apr; 15(4):322. . View in PubMed
Early juvenile idiopathic arthritis Rheum Dis Clin North Am. 2012 May; 38(2):355-72. . View in PubMed
Pediatric rheumatic disease in the intensive care unit: lessons learned from 15 years of experience in a tertiary care pediatric hospital Pediatr Crit Care Med. 2012 May; 13(3):e181-6. . View in PubMed
Acanthamoeba meningoencephalitis presenting as neuropsychiatric lupus in a pediatric patient Clin Exp Rheumatol. 2012 Mar-Apr; 30(2):272-6. . View in PubMed
Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions Adolesc Health Med Ther. 2012; 3:85-93. . View in PubMed
High dose infliximab in the treatment of refractory uveitis: does dose matter? ISRN Rheumatol. 2012; 2012:765380.. View in PubMed
A child with x-linked agammaglobulinemia and enthesitis-related arthritis Int J Rheumatol. 2011; 2011:175973. . View in PubMed
B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients Arthritis Rheum. 2009 Nov; 60(11):3400-9. . View in PubMed
Adalimumab in juvenile rheumatoid arthritis/juvenile idiopathic arthritis Expert Rev Clin Immunol. 2008 Sep; 4(5):549-58. . View in PubMed
MRI abnormalities in Behr syndrome Pediatr Neurol. 1994 May; 10(3):247-8. . View in PubMed
